Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Cardiac Surgery Trainees as "Skin-to-Skin" Operating Surgeons: Midterm Outcomes.

Bloom JP, Heng E, Auchincloss HG, Melnitchouk SI, D'Alessandro DA, Villavicencio MA, Sundt TM, Tolis G Jr.

Ann Thorac Surg. 2019 Jul;108(1):262-267. doi: 10.1016/j.athoracsur.2019.02.008. Epub 2019 Mar 14.

PMID:
30880141
2.

Giant coronary artery aneurysm: Cardiac gated CT as optimal exam.

Verdini D, Hedgire S, Auchincloss H, Isselbacher E, Sundt T, Ghoshhajra B.

J Cardiovasc Comput Tomogr. 2018 Dec 18. pii: S1934-5925(18)30349-6. doi: 10.1016/j.jcct.2018.12.003. [Epub ahead of print] No abstract available.

PMID:
30598345
3.

Tracheal stenosis-resection and reconstruction.

Auchincloss HG, Mathisen DJ.

Ann Cardiothorac Surg. 2018 Mar;7(2):306-308. doi: 10.21037/acs.2018.03.10. No abstract available.

4.

Complications after tracheal resection and reconstruction: prevention and treatment.

Auchincloss HG, Wright CD.

J Thorac Dis. 2016 Mar;8(Suppl 2):S160-7. doi: 10.3978/j.issn.2072-1439.2016.01.86. Review.

5.

Impact of Expanded Insurance Coverage on Racial Disparities in Vascular Disease: Insights From Massachusetts.

Loehrer AP, Hawkins AT, Auchincloss HG, Song Z, Hutter MM, Patel VI.

Ann Surg. 2016 Apr;263(4):705-11. doi: 10.1097/SLA.0000000000001310.

6.

Prevention and Management of Nerve Injuries in Thoracic Surgery.

Auchincloss HG, Donahue DM.

Thorac Surg Clin. 2015 Nov;25(4):509-15. doi: 10.1016/j.thorsurg.2015.07.012. Review.

PMID:
26515950
7.

Influence of Health Insurance Expansion on Disparities in the Treatment of Acute Cholecystitis.

Loehrer AP, Song Z, Auchincloss HG, Hutter MM.

Ann Surg. 2015 Jul;262(1):139-45. doi: 10.1097/SLA.0000000000000970.

8.

Massachusetts health care reform and reduced racial disparities in minimally invasive surgery.

Loehrer AP, Song Z, Auchincloss HG, Hutter MM.

JAMA Surg. 2013 Dec;148(12):1116-22. doi: 10.1001/jamasurg.2013.2750.

9.

Tracheal disruption from invasive pretracheal lymphadenopathy.

Auchincloss HG, Morse CR.

Ann Thorac Surg. 2013 Jan;95(1):e23. doi: 10.1016/j.athoracsur.2012.07.070. Epub 2012 Dec 25. No abstract available.

PMID:
23272888
10.

Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term triple therapy.

Koulmanda M, Qipo A, Fan Z, Smith N, Auchincloss H, Zheng XX, Strom TB.

Am J Transplant. 2012 May;12(5):1296-302. doi: 10.1111/j.1600-6143.2012.03973.x. Epub 2012 Mar 5.

11.

CTLA-4: not all costimulation is stimulatory.

Auchincloss H, Turka LA.

J Immunol. 2011 Oct 1;187(7):3457-8. doi: 10.4049/jimmunol.1102316. No abstract available.

12.

Role of nuclear factor of activated T cell (NFAT) transcription factors in skin and vascularized cardiac allograft rejection.

Ueno T, Yamada A, Ito T, Yeung MY, Gorbatov R, Shimizu T, Abdi R, Sayegh MH, Auchincloss H Jr, Najafian N.

Transplantation. 2011 Sep 15;92(5):e26-7. doi: 10.1097/TP.0b013e318228061c. No abstract available.

PMID:
21866037
13.

The Immune Tolerance Network at 10 years: tolerance research at the bedside.

Bluestone JA, Auchincloss H, Nepom GT, Rotrosen D, St Clair EW, Turka LA.

Nat Rev Immunol. 2010 Nov;10(11):797-803. doi: 10.1038/nri2869. Review.

PMID:
20972473
14.

Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.

Koulmanda M, Bhasin M, Hoffman L, Fan Z, Qipo A, Shi H, Bonner-Weir S, Putheti P, Degauque N, Libermann TA, Auchincloss H Jr, Flier JS, Strom TB.

Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16242-7. doi: 10.1073/pnas.0808031105. Epub 2008 Oct 13.

15.

Pathology of an islet transplant 2 years after transplantation: evidence for a nonimmunological loss.

Smith RN, Kent SC, Nagle J, Selig M, Iafrate AJ, Najafian N, Hafler DA, Auchincloss H, Orban T, Cagliero E.

Transplantation. 2008 Jul 15;86(1):54-62. doi: 10.1097/TP.0b013e318173a5da.

PMID:
18622278
16.

Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts.

Koulmanda M, Budo E, Bonner-Weir S, Qipo A, Putheti P, Degauque N, Shi H, Fan Z, Flier JS, Auchincloss H Jr, Zheng XX, Strom TB.

Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13074-9. Epub 2007 Aug 1.

17.

Beta 3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection.

Lacy-Hulbert A, Ueno T, Ito T, Jurewicz M, Izawa A, Smith RN, Chase CM, Tanaka K, Fiorina P, Russell PS, Auchincloss H Jr, Sayegh MH, Hynes RO, Abdi R.

Am J Transplant. 2007 May;7(5):1080-90. Epub 2007 Mar 12.

18.

Immunology research: challenges and opportunities in a time of budgetary constraint.

Hackett CJ, Rotrosen D, Auchincloss H, Fauci AS.

Nat Immunol. 2007 Feb;8(2):114-7.

PMID:
17242679
19.

International trial of the Edmonton protocol for islet transplantation.

Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR.

N Engl J Med. 2006 Sep 28;355(13):1318-30.

20.

Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure?

Koulmanda M, Smith RN, Qipo A, Weir G, Auchincloss H, Strom TB.

Am J Transplant. 2006 Apr;6(4):687-96.

21.

Role of CXC chemokine receptor 3 pathway in renal ischemic injury.

Fiorina P, Ansari MJ, Jurewicz M, Barry M, Ricchiuti V, Smith RN, Shea S, Means TK, Auchincloss H Jr, Luster AD, Sayegh MH, Abdi R.

J Am Soc Nephrol. 2006 Mar;17(3):716-23. Epub 2006 Feb 15.

22.

Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.

Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H Jr, Sayegh MH, Najafian N.

J Immunol. 2005 Jun 1;174(11):6648-56.

23.

CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.

Yamada A, Salama AD, Sho M, Najafian N, Ito T, Forman JP, Kewalramani R, Sandner S, Harada H, Clarkson MR, Mandelbrot DA, Sharpe AH, Oshima H, Yagita H, Chalasani G, Lakkis FG, Auchincloss H Jr, Sayegh MH.

J Immunol. 2005 Feb 1;174(3):1357-64.

24.

Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.

Koulmanda M, Laufer TM, Auchincloss H Jr, Smith RN.

Xenotransplantation. 2004 Nov;11(6):525-30.

PMID:
15479462
25.

Mechanism of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation.

Kishimoto K, Yuan X, Auchincloss H Jr, Sharpe AH, Mandelbrot DA, Sayegh MH.

J Am Soc Nephrol. 2004 Sep;15(9):2423-8.

26.

Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients.

Baid-Agrawal S, Delmonico FL, Tolkoff-Rubin NE, Farrell M, Williams WW, Shih V, Auchincloss H, Cosimi AB, Pascual M.

Transplantation. 2004 Apr 27;77(8):1199-202.

PMID:
15114085
27.

Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

Transplantation. 2004 Apr 15;77(7):990-7.

PMID:
15087759
28.

Clarence Cook Little (1888-1971): the genetic basis of transplant immunology.

Auchincloss H Jr, Winn HJ.

Am J Transplant. 2004 Feb;4(2):155-9. No abstract available.

29.

Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.

Abdi R, Means TK, Ito T, Smith RN, Najafian N, Jurewicz M, Tchipachvili V, Charo I, Auchincloss H Jr, Sayegh MH, Luster AD.

J Immunol. 2004 Jan 15;172(2):767-75.

30.

No tolerance for depletion.

Auchincloss H.

Nat Med. 2004 Jan;10(1):21-3. No abstract available.

PMID:
14702625
31.

Effects of streptozotocin on autoimmune diabetes in NOD mice.

Koulmanda M, Qipo A, Auchincloss H Jr, Smith RN.

Clin Exp Immunol. 2003 Nov;134(2):210-6.

32.

A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.

Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, Ko DS, Williams WW, Chandraker A, Delmonico FL, Auchincloss H, Cosimi AB.

Transplantation. 2003 Sep 15;76(5):798-802.

PMID:
14501856
33.

Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice.

Makhlouf L, Yamada A, Ito T, Abdi R, Ansari MJ, Khuong CQ, Winn HJ, Auchincloss H Jr, Sayegh MH.

J Am Soc Nephrol. 2003 Aug;14(8):2168-75.

34.

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.

Ansari MJ, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, Yamazaki T, Azuma M, Iwai H, Khoury SJ, Auchincloss H Jr, Sayegh MH.

J Exp Med. 2003 Jul 7;198(1):63-9.

35.

The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis).

Koulmanda M, Qipo A, Chebrolu S, O'Neil J, Auchincloss H, Smith RN.

Am J Transplant. 2003 Mar;3(3):267-72.

36.

Pig islet xenografts are resistant to autoimmune destruction by non-obese diabetic recipients after anti-CD4 treatment.

Koulmanda M, Qipo A, Smith RN, Auchincloss H Jr.

Xenotransplantation. 2003 Mar;10(2):178-84.

PMID:
12588650
37.

Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy.

Baid S, Tolkoff-Rubin N, Saidman S, Chung R, Williams WW, Auchincloss H, Colvin RB, Delmonico FL, Cosimi AB, Pascual M.

Am J Transplant. 2003 Jan;3(1):74-8.

38.

Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection.

Yamada A, Laufer TM, Gerth AJ, Chase CM, Colvin RB, Russell PS, Sayegh MH, Auchincloss H Jr.

Am J Transplant. 2003 Jan;3(1):23-7.

39.
40.

Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T cell model.

Bhandoola A, Tai X, Eckhaus M, Auchincloss H, Mason K, Rubin SA, Carbone KM, Grossman Z, Rosenberg AS, Singer A.

Immunity. 2002 Oct;17(4):425-36.

41.

The kidney transplant program at the Massachusetts general hospital.

Pascual M, Tolkoff-Rubin N, Farrell ML, Williams W, Auchincloss H, Ko D, Saidman S, Colvin RB, Cosimi AB, Delmonico FL.

Clin Transpl. 2001:123-30.

PMID:
12211774
42.

The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection.

Abdi R, Smith RN, Makhlouf L, Najafian N, Luster AD, Auchincloss H Jr, Sayegh MH.

Diabetes. 2002 Aug;51(8):2489-95.

43.
44.

Transplanting cloned cells into therapeutic promise.

Auchincloss H, Bonventre JV.

Nat Biotechnol. 2002 Jul;20(7):665-6. No abstract available.

PMID:
12089546
45.

TNF:TNF-R T-Cell costimulatory pathways in transplantation.

Yamada A, Salama AD, Najafian N, Auchincloss H Jr, Sayegh MH.

Transplant Proc. 2001 Nov-Dec;33(7-8):3070-1. No abstract available.

PMID:
11750320
46.

Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade.

Yamada A, Chandraker A, Laufer TM, Gerth AJ, Sayegh MH, Auchincloss H Jr.

J Immunol. 2001 Nov 15;167(10):5522-6.

47.

Long-term islet allograft function in the absence of chronic immunosuppression: a case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor.

Kawai T, Sogawa H, Koulmanda M, Smith RN, O'Neil JJ, Wee SL, Boskovic S, Sykes M, Colvin RB, Sachs DH, Auchincloss H Jr, Cosimi AB, C Ko DS.

Transplantation. 2001 Jul 27;72(2):351-4.

PMID:
11477369
48.

Rejection of mouse cardiac allografts by costimulation in trans.

Mandelbrot DA, Kishimoto K, Auchincloss H Jr, Sharpe AH, Sayegh MH.

J Immunol. 2001 Aug 1;167(3):1174-8.

49.

CD28-independent costimulation of T cells in alloimmune responses.

Yamada A, Kishimoto K, Dong VM, Sho M, Salama AD, Anosova NG, Benichou G, Mandelbrot DA, Sharpe AH, Turka LA, Auchincloss H Jr, Sayegh MH.

J Immunol. 2001 Jul 1;167(1):140-6.

50.

Involvement of the direct and indirect pathways of allorecognition in tolerance induction.

Womer KL, Sayegh MH, Auchincloss H Jr.

Philos Trans R Soc Lond B Biol Sci. 2001 May 29;356(1409):639-47. Review.

Supplemental Content

Loading ...
Support Center